The doses follow the FDA-approved escalation schedule from 2.5 mg through 15 mg
This isnt about denying accessits about appropriate medical care and avoiding unnecessary medication risks for people who dont medically need these drugs
Addressing this unmet need head-on is critical, and while there are pharmaceutical treatments for the excessive sleepiness associated with OSA, tirzepatide has the potential to be the first pharmaceutical treatment for the underlying disease. Currently, the gold standard of treatment for OSA is CPAP therapy
According to the National Capital Poison Center, in 2005, a 5-year-old autistic boy died during intravenous chelation therapy using the drug disodium edetate
The Endocrine Society's Clinical Practice Guideline on pharmacological management of obesity recommends considering AOMs for patients who experience weight regain after bariatric surgery, particularly when lifestyle modifications prove insufficient
Oral formulations may expand access to treatment, particularly for those reluctant to use injectable medications
